Clinical Trial Update: Concurrent Boost Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating concurrent boost radiotherapy for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED